Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro
- PMID: 26611396
- DOI: 10.1016/j.antiviral.2015.11.007
Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro
Abstract
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes chikungunya fever and has infected millions of people mainly in developing countries. The associated disease is characterized by rash, high fever, and severe arthritis that can persist for years. CHIKV has adapted to Aedes albopictus, which also inhabits temperate regions including Europe and the United States of America. CHIKV has recently caused large outbreaks in Latin America. No treatment or licensed CHIKV vaccine exists. Traditional medicines are known to have anti-viral effects; therefore, we examined whether curcumin or Boswellia serrata gum resin extract have antiviral activity against CHIKV. Both compounds blocked entry of CHIKV Env-pseudotyped lentiviral vectors and inhibited CHIKV infection in vitro. In addition, vesicular stomatitis virus vector particles and viral infections were also inhibited to the same extent, indicating a broad antiviral activity. Although the bioavailability of these compounds is rather poor, they might be used as a lead structure to develop more effective antiviral drugs or might be used topically to prevent CHIKV spread in the skin after mosquito bites.
Keywords: Boswellic acid; Chikungunya virus; Curcumin; Traditional medicine; Vesicular stomatitis virus.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Chikungunya virus infections: time to act, time to treat.Curr Opin Virol. 2017 Jun;24:25-30. doi: 10.1016/j.coviro.2017.03.016. Epub 2017 Apr 14. Curr Opin Virol. 2017. PMID: 28414993 Review.
-
Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.Curr Comput Aided Drug Des. 2017 Nov 10;13(4):346-361. doi: 10.2174/1573409913666170309145308. Curr Comput Aided Drug Des. 2017. PMID: 28294048 Review.
-
Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.Virol J. 2016 Aug 31;13(1):149. doi: 10.1186/s12985-016-0607-2. Virol J. 2016. PMID: 27581733 Free PMC article.
-
Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.Acta Virol. 2015 Jun;59(2):189-93. doi: 10.4149/av_2015_02_189. Acta Virol. 2015. PMID: 26104337
-
The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.Antiviral Res. 2015 Jan;113:1-3. doi: 10.1016/j.antiviral.2014.11.001. Epub 2014 Nov 11. Antiviral Res. 2015. PMID: 25446334
Cited by
-
Identification of new pharmacophore against SARS-CoV-2 spike protein by multi-fold computational and biochemical techniques.Sci Rep. 2024 Feb 13;14(1):3590. doi: 10.1038/s41598-024-53911-6. Sci Rep. 2024. PMID: 38351259 Free PMC article.
-
The journey of boswellic acids from synthesis to pharmacological activities.Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar;397(3):1477-1504. doi: 10.1007/s00210-023-02725-w. Epub 2023 Sep 23. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37740772 Free PMC article. Review.
-
Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors.Int J Mol Sci. 2023 Mar 27;24(7):6298. doi: 10.3390/ijms24076298. Int J Mol Sci. 2023. PMID: 37047270 Free PMC article.
-
Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach.Front Cell Infect Microbiol. 2023 Mar 22;13:1157627. doi: 10.3389/fcimb.2023.1157627. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37033493 Free PMC article.
-
Evolution and immunopathology of chikungunya virus informs therapeutic development.Dis Model Mech. 2023 Apr 1;16(4):dmm049804. doi: 10.1242/dmm.049804. Epub 2023 Apr 4. Dis Model Mech. 2023. PMID: 37014125 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical